Asante Gold Corporation is a Ghana focused gold exploration and development company headquartered in Vancouver. Ghana is Africa’s number two gold producer and ninth in the World, and hosts numerous +10 million ounce gold deposits, including Obuasi, Tarkwa, and Ahafo. Some of the world’s leading gold producers are active here including Newmont, AngloGold Ashanti, Goldfields, Perseus and Kinross.
The Board is highly experienced: Douglas MacQuarrie President & CEO (former CEO PMI Gold/now owned by Asanko Gold), Bashir Ahmed VP (former Mine Manager of AngloGold Ashanti Obuasi Mine), Alex Heath (former investment banker Salman Partners) and Florian Riedl-Riedenstein (former investment banker). Our Advisors to the Board include Alan McKerron former Director New Business for Anglo American; Nana Prah, Special Advisor to the Government of Ghana and Chairman of Perseus Ghana; Kevin Thomson (former Exploration Manager Newmont and Perseus); and Eric Ewen, Prospector and discoverer of Keegan (now Asanko Gold) 5 Moz Esaase orebody.
Our main focus is to put our high grade Kubi Gold mine back into production as an underground mine at circa 40koz per year, via an exploration decline and toll milling. We are also exploring for the next big one - on our Keyhole concessions (optioned from Sikasante Mining Company Limited); Betenase Option (optioned from Perseus Ghana) and Fahiakoba concession; and, subject to final closing and additional third party and governmental transfers and approvals, an additional eight concessions - two adjoining Kubi and six along strike to the south west of the the Asanko/Goldfields gold Mine. These licenses have been explored in the past by many companies including BHP, Nevsun Resources and PMI Gold Corporation with many significant drill ‘discovery’ holes already outlined and requiring follow up detailed exploration. We plan to capitalize on this gold-rich and growing mining environment by continuing to build our assets through exploration, development and acquisitions.
- CSE : ASE
- Frankfurt : 1A9 LEI# 529900F9PV1G9S5YD446
- OTC : ASGOF